CTOR

Citius Oncology, Inc.

• TipRanks·4d ago

  Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV) and Citius Oncology (CTOR)

• Dow Jones·05/15 20:32

  *Citius Oncology 2Q Rev $1.67M >CTOR

• Dow Jones·05/15 20:32

  *Citius Oncology 2Q Loss/Shr 27c >CTOR

• Dow Jones·05/15 20:30

  Press Release: Citius Oncology, Inc. Reports -2-

• Dow Jones·05/15 20:30

  Press Release: Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

• TipRanks·05/06 13:21

  Citius Oncology Secures New Financing to Support LYMPHIR

• Dow Jones·05/06 00:00

  Press Release: Citius Oncology, Inc. Secures Up -2-

• Dow Jones·05/06 00:00

  Press Release: Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR(R) Commercialization

• TipRanks·04/29 22:15

  Citius Oncology Begins First European Expansion of LYMPHIR

• TipRanks·04/29 14:53

  Citius Oncology announces initial shipment of LYMPHIR to Europe

• TipRanks·04/28 22:30

  Citius Oncology Faces Nasdaq Non-Compliance, Delisting Risk Looms

• TipRanks·04/01 03:32

  Citius Oncology highlights early LYMPHIR commercial traction, expansion

• TipRanks·03/31 13:40

  Citius Oncology provides commercial update on lymphir launch

• Benzinga·03/31 13:14

  Citius Oncology Provides Commercial Update On U.S. Launch Of LYMPHIR For Treatment Of CTCL, Highlighting Continued Adoption And Advancing Investigator-Led Clinical Studies

• Benzinga·03/18 12:05

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session